SEGMENT INFORMATION (Tables)

9 Months Ended

Sep. 30, 2013

SEGMENT INFORMATION

Information about reportable segments

The table below presents information about Edwards Lifesciences' reportable segments (in millions):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
Segment Net Sales
United States	$	232.1	$	193.5	$	700.5	$	587.1
Europe		146.2		129.7		462.4		430.9
Japan		69.2		70.7		209.5		214.0
Rest of world		65.4		62.0		183.0		171.7
Total segment net sales	$	512.9	$	455.9	$	1,555.4	$	1,403.7
Segment Pre-tax Income
United States	$	135.1	$	109.2	$	410.6	$	330.2
Europe		66.2		53.4		212.4		185.2
Japan		31.6		36.5		102.0		110.2
Rest of world		20.1		19.3		50.1		48.5
Total segment pre-tax income	$	253.0	$	218.4	$	775.1	$	674.1

Reconciliations of segment net sales to consolidated net sales and segment pre-tax income to consolidated pre-tax income

The table below presents reconciliations of segment net sales to consolidated net sales and segment pre-tax income to consolidated pre-tax income (in millions):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2013			2012			2013			2012
Net Sales Reconciliation
Segment net sales	$	512.9		$	455.9		$	1,555.4		$	1,403.7
Foreign currency		(17.3	)		(8.0	)		(45.9	)		(14.6	)
Consolidated net sales	$	495.6		$	447.9		$	1,509.5		$	1,389.1
Pre-tax Income Reconciliation
Segment pre-tax income	$	253.0		$	218.4		$	775.1		$	674.1
Unallocated amounts:
Corporate items		(148.8	)		(127.4	)		(440.0	)		(399.1	)
Special gains (charges)		—			—			83.6			(7.0	)
Interest (expense) income, net		(1.0	)		0.3			(1.2	)		0.4
Foreign currency		(3.3	)		2.1			(3.7	)		0.5
Consolidated pre-tax income	$	99.9		$	93.4		$	413.8		$	268.9

Enterprise-wide information

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
	(in millions)
Net Sales by Geographic Area
United States	$	232.1	$	193.6	$	700.5	$	587.2
Europe		144.4		121.8		454.2		417.1
Japan		56.7		71.8		176.0		214.9
Rest of world		62.4		60.7		178.8		169.9
	$	495.6	$	447.9	$	1,509.5	$	1,389.1
Net Sales by Major Product and Service Area
Surgical Heart Valve Therapy	$	191.8	$	185.7	$	594.2	$	589.8
Transcatheter Heart Valves		172.0		123.8		523.8		391.1
Critical Care		131.8		138.4		391.5		408.2
	$	495.6	$	447.9	$	1,509.5	$	1,389.1

	September 30, 2013		December 31, 2012
	(in millions)
Long-lived Tangible Assets by Geographic Area
United States	$	293.4	$	263.4
International		146.6		136.2
	$	440.0	$	399.6